Anti‐BCMA Immuno‐NanoPET Radiotracers for Improved Detection of Multiple Myeloma

Anti‐BCMA Immuno‐NanoPET Radiotracers for Improved Detection of Multiple Myeloma

Current clinical imaging modalities for the sensitive and specific detection of multiple myeloma (MM) rely on nonspecific imaging contrast agents based on gadolinium chelates for magnetic resonance imaging (MRI) or for 18 F-FDG-directed and combined positron emission tomography (PET) and computed to...

Full description

Bibliographic Details
Main Authors: Thomas, Eloise, Mathieu, Clélia, Moreno‐Gaona, Patricia, Mittelheisser, Vincent, Lux, François, Tillement, Olivier, Pivot, Xavier, Ghoroghchian, Paiman Peter, Detappe, Alexandre
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:English
Published: Wiley 2022
Online Access:https://hdl.handle.net/1721.1/141216

Internet

https://hdl.handle.net/1721.1/141216

Similar Items